Onderzoeker
Triana Lobatón Ortega
- Trefwoorden:Geneeskunde
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 sep 2019 → Heden
Projecten
1 - 1 of 1
- Microbes-4-Immunity: single-cell gebaseerde sortering en onderzoek van het functionele microbioom in intestinale en extra-intestinale immuunhomeostase.Vanaf1 jan 2022 → HedenFinanciering: BOF - projecten
Publicaties
1 - 10 van 77
- Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate‐like T cell signature(2023)
Auteurs: Céline Mortier, Katrien Quintelier, Ann-Sophie De Craemer, Thomas Renson, Liselotte Deroo, Emilie Dumas, Eveline Verheugen, Julie Coudenys, Tine Decruy, Zuzanna Łukasik, et al.
Pagina's: 1969 - 1982 - Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis(2023)
Auteurs: Koen Venken, Matthias Jarlborg, Tine Decruy, Céline Mortier, Carolien Vlieghe, Elisabeth Gilis, Ann-Sophie De Craemer, Julie Coudenys, Isabelle Cambré, Devan Fleury, et al.
Pagina's: 1076 - 1090 - Editorial : LAG‐3‐depleting monoclonal antibody : a potential treatment for patients with ulcerative colitis?(2023)
Auteurs: Triana Lobatón Ortega, Marie Truyens
Pagina's: 359 - 360 - Comparison of short- and long-term effectiveness between anti-TNF and ustekinumab after vedolizumab failure as first-line therapy in Crohn’s disease : a multi-center retrospective cohort study(2023)
Auteurs: Ahmad Albshesh, Lian Bannon, Tali Sharar Fischler, Marie Truyens, Stephan R. Vavricka, Katja Tepes, Daniela Pugliese, Edoardo V. Savarino, Eran Zittan, David Drobne, et al.
- SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study(2023)
Auteurs: Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, et al.
- The PROPER study : a 48-week, pan-European, real-world study of biosimilar SB5 following transition from reference adalimumab in patients with immune-mediated inflammatory disease(2023)
Auteurs: Ulf Mueller-Ladner, Axel Dignass, Karl Gaffney, Deepak Jadon, Marco Matucci-Cerinic, Triana Lobatón Ortega, Philippe Carron, Javier P. Gisbert, Ira Pande, Maximilian Utzinger, et al.
Pagina's: 873 - 889 - Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation(2023)
Auteurs: Ann-Sophie De Craemer, Torsten Witte, Triana Lobatón Ortega, Anne Hoorens, Martine De Vos, Claude Cuvelier, Sebastiaan J. Vastert, Xenofon Baraliakos, Filip Van den Bosch, Dirk Elewaut
Pagina's: 984 - 990 - Autoimmune pancreatitis in patients with inflammatory bowel disease : a real-world multicentre collaborative ECCO CONFER study(2023)
Auteurs: Piotr Eder, Bram Verstock, Emma Culver, Gabriele Dragoni, Lea Isabell Kredel, Joanna Wypych, Ana Garcia Garcia de Paredes, Magdalena Kaniewska, Haim Leibovitzh, Triana Lobatón Ortega, et al.
Pagina's: 1791 - 1799 - A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)(2022)Volume: 16
Auteurs: Marie Truyens, Triana Lobatón Ortega, Anneleen Peeters, Marc Ferrante, Séverine Vermeire, Peter Bossuyt, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, et al.
Pagina's: i029 - i032 - Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study(2022)
Auteurs: Cara De Galan, Sophie Van Welden, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens